Document and Entity Information Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] ADR [Member] American Depositary Shares (ADSs) Common Stock [Member] ORDINARY SHARES Ordinary shares Document Information [Line Items] Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol No Trading Symbol Flag Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalent Cash and cash equivalents Short-Term Investments Short-term investments Other Receivables, Net, Current Other receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Operating Lease, Right-of-Use Asset Operating right-of-use assets Other Assets, Noncurrent Other non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and shareholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable The amount of current portion of accrued expenses and other liabilities as at the end of the reporting period. Accrued Expenses and Other Liabilities, Current Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Operating Lease, Liability, Current Less: current portion Operating lease liabilities, current portion Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Operating lease liabilities, net of current portion Operating lease liability, net of current portion Other Liabilities, Noncurrent Other non-current liabilities Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 5) Equity, Attributable to Parent [Abstract] Shareholders' equity: Preferred Stock, Value, Issued Undesignated shares - $0.0001 par value; 100,000 shares authorized as of June 30, 2026 and December 31, 2025 Common Stock, Value, Issued Ordinary shares - $0.0001 par value; 500,000 shares authorized as of June 30, 2026 and December 31, 2025; 213,655 and 212,513 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive (loss) income Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Ending balance Beginning balance Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Preferred Stock, Par or Stated Value Per Share Undesignated shares, par value Preferred Stock, Shares Authorized Undesignated shares, shares authorized Common Stock, Par or Stated Value Per Share Ordinary shares, par value (in dollars per share) Common Stock, Shares Authorized Ordinary shares, shares authorized Common Stock, Shares, Issued Ordinary shares, shares issued Common Stock, Shares, Outstanding Ordinary shares, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations The amount of interest and other income (expense) net. Interest and Other Income (Expense), Net Interest and other income, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before provision for income taxes Income Tax Expense (Benefit) Provision for income taxes Net loss attributable to ordinary shareholders Net loss Earnings Per Share, Basic Net loss per share, basic Net loss per share attributable to ordinary shareholders, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share, diluted Net loss per share attributable to ordinary shareholders, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders, basic (in shares) Weighted average shares used to compute net loss per share, basic Weighted Average Number of Shares Outstanding, Diluted Weighted-average ordinary shares used in computing net loss per share attributable to ordinary shareholders, diluted (in shares) Weighted average shares used to compute net loss per share, diluted Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive loss: OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Unrealized loss on investments, net Unrealized loss on investments, net Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Additional Paid-in Capital [Member] ADDITIONAL PAID-IN CAPITAL AOCI Attributable to Parent [Member] ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Retained Earnings [Member] ACCUMULATED DEFICIT Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares, Outstanding Ending balance (in shares) Beginning balance (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of ordinary shares upon exercise of vested share options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of ordinary shares upon exercise of vested share options (in shares) Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of ordinary shares pursuant to employee share purchase plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of ordinary shares pursuant to employee share purchase plan (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Issuance of ordinary shares upon vesting of restricted share units (in shares) Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Shares withheld for taxes Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Shares withheld for taxes (in shares) Amount of increase in additional paid in capital (APIC) resulting from depository issuance cost offset. Adjustments to Additional Paid in Capital, Depository Issuance Cost Offset Depository issuance cost offset APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Share-based compensation expense CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Share-Based Payment Arrangement, Noncash Expense Share-based compensation expense Depreciation Depreciation expense Asset Retirement Obligation, Accretion Expense Accretion of asset retirement obligation The amount of non cash lease expense. Non Cash Lease Expense Non-cash lease expense Investment Income, Net, Amortization of Discount and Premium Accretion of net investment discounts Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Other Receivables Other receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accounts Payable Accounts payable The increase (decrease) during the reporting period in the aggregate amount of accrued expenses and other current liabilities during the reporting period. Increase (Decrease) in Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities Increase (Decrease) in Operating Lease Liability Operating lease liabilities Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities Payments to Acquire Short-Term Investments Purchases of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Proceeds from maturities of short-term investments Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash (used in) provided by investing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities Payments of Debt Issuance Costs Payments of offering costs Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Proceeds from issuance of ordinary shares under employee share purchase plan Proceeds from Stock Options Exercised Proceeds from exercise of share options Payment, Tax Withholding, Share-Based Payment Arrangement Payment of taxes on restricted share units withheld for taxes Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net change in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation End of the period Beginning of the period Noncash Investing and Financing Items [Abstract] Supplemental disclosures of noncash investing and financing activities Capital Expenditures Incurred but Not yet Paid Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities The amount of offering costs included in accounts payable and accrued expenses and other current liabilities. Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities Offering costs included in accounts payable and accrued expenses and other current liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating lease right-of-use assets obtained in exchange for new lease liabilities Asset Retirement Obligation, Period Increase (Decrease) Recognition of asset retirement obligation Organization and Nature of the Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Nature of the Business Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Composition of Certain Consolidated Financial Statement Line Items Supplemental Balance Sheet Disclosures [Text Block] Composition of Certain Consolidated Financial Statement Line Items Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Shareholders' Equity Share-Based Payment Arrangement [Text Block] Shareholders' Equity No definition available. License Agreement Entire disclosure for license agreements. License Agreement Disclosure [Text Block] License Agreement Asset Purchase Agreement The entire disclosure for asset sale. Asset Sale [Text Block] Asset Purchase Agreement No definition available. Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Collaboration Agreements Net Loss Per Share Earnings Per Share [Text Block] Net Loss Per Share Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Disclosure of accounting policy for unaudited interim financial information. Unaudited Interim Financial Information Policy [Policy Text Block] Unaudited Interim Financial Information Use of Estimates, Policy [Policy Text Block] Use of Estimates Segment Reporting, Policy [Policy Text Block] Segments Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Disclosure of accounting policy for risk and uncertainties. Risk And Uncertainties Policy [Policy Text Block] Risks and Uncertainties Fair Value Measurement, Policy [Policy Text Block] Fair Value of Financial Instruments Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Attributable to Ordinary Shareholders New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of segment net loss, including significant segment expenses Tabular disclosure of accrued expenses and other current liabilities. Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of financial assets measured at fair value on a recurring basis Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of maturities of operating lease liabilities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Shareholders' Equity Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of recognized share-based compensation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net loss per share attributable to ordinary shareholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of outstanding shares of potentially dilutive securities excluded from the computation of diluted net loss per share Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to an at-the-market common stock offering program (the "ATM Program"). At The Market Common Stock Offering Program [Member] At the Market offering Represents information pertaining to 2025 follow-on offering. Follow On Offering 2025 [Member] Follow on offering 2025 2025 Follow-On Offering Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to pre-funded warrants. Pre Funded Warrants [Member] Prefunded warrants Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event Subsidiary, Sale of Stock [Line Items] Organization and Nature of the Business Aggregate number of shares agreed to sell. Sale of Stock, Aggregate Number of Shares Agreed to Sell Aggregate shares agreed to sell The option granted to purchase maximum number of shares. Option Granted to Purchase Maximum Number of Shares Option granted to purchase maximum number of shares Sale of Stock, Number of Shares Issued in Transaction Sale of Stock, number of shares issued in transaction Sale of Stock, Price Per Share Purchase Price Sale of Stock, Consideration Received on Transaction Net proceeds after deducting The maximum amount of issuance value under the agreement. Sale of Stock, Authorized Issuance Amount Maximum amount of issuance value Stock Issued During Period, Shares, New Issues Shares issued The cash inflow from the additional capital contribution to the entity, before deducting sales commission, offering expenses. Gross Proceeds From Issuance Of Common Stock Gross proceeds The value of stock that remains available for sale in a sale of stock transaction Sale of Stock, Remaining Available for Sale Remaining value of common stock under ATM program Amount of increased shares available to be sold. Increased Shares Available to be Sold Increased shares available to be sold Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of shares Public offering price per share or per unit of warrants or rights outstanding. Class of Warrant or Right, Public Offering Price Of Warrants or Rights Price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price Proceeds from Issuance or Sale of Equity Net cash proceeds Proceeds from Issuance of Common Stock Net proceeds Cash, Cash Equivalents, and Short-Term Investments Cash, cash equivalents and short-term investments Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents the information pertaining to single reportable segment. Single Reportable Segment [Member] Single Reporting Segment Segment Reporting Information [Line Items] Summary of Significant Accounting Policies Number of Reportable Segments Number of reportable segments Number of Operating Segments Number of operating segments Amount of expense for discovery research and development. Discovery Research and Development Expense Discovery research and development Amount of expense for manufacturing. Manufacturing Expense Manufacturing Amount of expense for clinical research and development. Clinical Research and Development Expense Clinical research and development Other Research and Development Expense Other research and development expenses Employee-related Liabilities, Current Accrued compensation Carrying amount as of the balance sheet date of current portion of accrued research and development expenses. Accrued Research And Development Expenses, Current Accrued research and development expenses Carrying amount as of the balance sheet date of current portion of accrued clinical expenses. Accrued Clinical Expenses, Current Accrued clinical expenses Accrued Professional Fees, Current Accrued professional services Other Accrued Liabilities, Current Accrued other liabilities Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] LEVEL 1 Fair Value, Inputs, Level 2 [Member] LEVEL 2 Financial Instrument [Axis] Financial Instruments [Domain] Money Market Funds [Member] Money market funds US Government Debt Securities [Member] U.S. government bonds US Government Agencies Debt Securities [Member] U.S. government agency bonds Corporate Debt Securities [Member] Corporate debt securities Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements Assets, Fair Value Disclosure Total fair value of financial assets Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss AMORTIZED COST Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax GROSS UNREALIZED LOSSES Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax GROSS UNREALIZED GAINS Debt Securities, Available-for-Sale, Excluding Accrued Interest FAIR VALUE Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Transfers in and out of Level 3 Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Contractual maturities of investments within one year Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through second year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date. Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Two Years, Fair Value Contractual maturities of investments after one year through two years Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest Allowance for credit losses The amount of impairment of marketable securities. Impairment of Marketable Securities Impairment losses Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (remaining six months) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three 2029 Lessee, Operating Lease, Liability, to be Paid Total undiscounted lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Operating Lease, Liability Total operating lease liability Lessee, Lease, Description [Table] Location, Statement of Financial Position, Balance [Axis] Lessee, Lease, Description [Line Items] Commitments and Contingencies Operating Lease, Cost Operating lease cost Short-Term Lease, Cost Short-term lease costs Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term (in years) Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate (as percent) Operating Lease, Payments Cash paid Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] Tranche one Share-Based Payment Arrangement, Tranche Two [Member] Tranche two Share-Based Payment Arrangement, Tranche Three [Member] Tranche three Grantee Status [Axis] Grantee Status [Domain] Share-Based Payment Arrangement, Employee [Member] Employee Represents the information pertaining to performance based restricted stock units member. Performance Based Restricted Stock Units [Member] Performance Share Units Represents the information pertaining to restricted share units with service and performance conditions granted in March 2026 (the "2026 PSUs"). Performance Share Units 2026 [Member] 2026 PSUs Dividends, Common Stock Dividends on ordinary shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Shares granted The number of tranches under the share based award as per the compensation arrangement. Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Tranches Number of tranches The number of milestones achievement probable under the share based award as per the compensation arrangement. Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Milestones, Achievement Probable Number of milestones achievement probable Share-Based Payment Arrangement, Expense Share-based compensation expense Total share-based compensation The number of milestones achievement certified under the share based award as per the compensation arrangement. Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Milestones, Achievement Certified Number of milestones achievement certified The number of milestones under the share based award as per the compensation arrangement. Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Milestones Number Of milestones Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vesting percentage Aggregate fair value of nonvested award under share-based payment arrangement. Share-Based Compensation Arrangement by Share-Based Payment Award, Other than Options, Aggregate Fair Value Aggregate fair value Number of warrants issued during the period. Number Of Warrants Issued Number of warrants issued The amount of issuance costs and underwriting discount incurred on issuance of pre-funded warrants. Warrants Issuance Costs And Underwriting Discount Issuance of pre-funded warrants, issuance costs and underwriting discounts Proceeds from Issuance of Warrants Proceeds from issuance of pre-funded warrants Number of warrants which have been exercised. Warrants Exercised Warrants exercised Location, Statement of Income, Balance [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement [Member] GNE Agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents information pertaining to Genentech, Inc. Genentech Inc [Member] Genentech Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] License Agreement Collaboration Agreements Amount of upfront payment received in relation to license agreement. License Agreement, Upfront Payment Received Upfront payment received Threshold number of days of prior written notice to terminate license agreement. License Agreement, Threshold Number Of Days Of Prior Written Notice For Termination Agreement termination period The amount of consideration the company received or expects to receive under the license agreement. License Agreement, Transaction Price Transaction price Disclosure of information about transaction recognized separately from asset sale. Asset Sale [Table] Asset Sale [Line Item] Asset Purchase Agreement Amount of initial payments receivable from asset sale agreement. Asset Sale, Initial Payments Initial payments Amount of contingent milestone payments receivable from asset sale agreement. Asset Sale, Contingent Milestone Payments Contingent milestone payments Amount of gain (loss) on sale or disposal of non-financial assets. Gain (Loss) on Disposition of Non-Financial Assets Gains on sale of non-financial assets Related Party Transaction [Axis] Related Party Transaction [Domain] Represents information pertaining to use of software platform for research purposes. Software Platform Use for Research Purposes [Member] Software platform use for research purposes Represents information pertaining to Schrodinger, Inc. Schrodinger, Inc. [Member] Schrodinger, Inc. Represents the information pertaining to Lhotse Collaboration Agreement. Lhotse Collaboration Agreement [Member] Lhotse Collaboration Agreement Represents the information pertaining to Aconcagua Collaboration Agreement. Aconcagua Collaboration Agreement [Member] Aconcagua Collaboration Agreement The amount of development and regulatory payments payable under the collaboration agreement. Collaboration Agreement Development and Regulatory Milestone Payments Payable Aggregate payment Term of Royalty under the collaboration agreement. Collaboration Agreement, Royalty Term Collaboration agreement term Extension term of Royalty under the collaboration agreement by mutual written agreement of the parties. Collaboration Agreement, Royalty Extension Term Collaboration agreement extension term The amount of milestone or royalty payments paid or accrued under the collaboration agreement. Collaboration Agreement Milestone or Royalty Payments Payable Payments paid or accrued Number of milestones achieved has part of collaboration agreement. Collaboration Agreement, Number of Milestones Achieved Number of Milestones Net Income (Loss) Attributable to Parent [Abstract] Numerator: Earnings Per Share Reconciliation [Abstract] Denominator: Weighted Average Number of Shares Issued, Basic Weighted-average ordinary shares outstanding Weighted Average Number of Shares, Contingently Issuable Add: weighted average of ordinary shares to be issued upon exercise of Pre-Funded Warrants Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Options to purchase ordinary shares Restricted Stock Units (RSUs) [Member] Restricted share units Unvested restricted share units Employee Stock [Member] Shares committed under ESPP ESPP Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss Per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total